Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.1466
+0.0046 (3.24%)
Mar 3, 2026, 1:58 PM EST - Market open
Jin Medical International Revenue
In the fiscal year ending September 30, 2025, Jin Medical International had annual revenue of $20.69M, down -11.98%. Jin Medical International had revenue of $10.81M in the half year ending September 30, 2025, with 12.93% growth.
Revenue (ttm)
$20.69M
Revenue Growth
-11.98%
P/S Ratio
1.10
Revenue / Employee
$75,778
Employees
273
Market Cap
22.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 20.69M | -2.81M | -11.98% |
| Sep 30, 2024 | 23.50M | 3.68M | 18.57% |
| Sep 30, 2023 | 19.82M | 630.92K | 3.29% |
| Sep 30, 2022 | 19.19M | -1.57M | -7.58% |
| Sep 30, 2021 | 20.76M | 4.57M | 28.22% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.37M |
| Retractable Technologies | 37.90M |
| Bionano Genomics | 28.72M |
| Precision Optics Corporation | 24.42M |
| Nephros | 17.93M |
| Ekso Bionics Holdings | 12.80M |
| NEXGEL | 11.67M |
| Milestone Scientific | 8.93M |
ZJYL News
- 26 days ago - Jin Medical CEO Fireside Chat - PRNewsWire
- 5 weeks ago - Jin Medical International Ltd. To Host Management Fireside Chat - PRNewsWire
- 5 weeks ago - Jin Medical Announces the Official Commencement Date of Chuzhou Facility - PRNewsWire
- 8 months ago - Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility - GlobeNewsWire
- 10 months ago - Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance - GlobeNewsWire
- 1 year ago - Construction of JinMed's New Facility Begins in Chuzhou, China - GlobeNewsWire
- 1 year ago - ZJYL Sees a Stock Surge of 5.04% Amid Positive Financial Performance - GuruFocus
- 1 year ago - Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga